MyMyelomaTeam

IgD myeloma is a rare subtype of multiple myeloma. It's classified based on the type of abnormal protein (called M protein) that the cancerous plasma cells produce — in this case, IgD heavy chains. Here are some key things to know about IgD myeloma:

- It is one of the rarer forms of myeloma, alongside IgE and IgM subtypes Show Full Answer

IgD myeloma is a rare subtype of multiple myeloma. It's classified based on the type of abnormal protein (called M protein) that the cancerous plasma cells produce — in this case, IgD heavy chains. Here are some key things to know about IgD myeloma:

- It is one of the rarer forms of myeloma, alongside IgE and IgM subtypes
- IgD myeloma is often associated with a higher risk of plasma cell leukemia, which means the myeloma cells can spill into the bloodstream
- Blood and urine tests, including a test called immunofixation electrophoresis (IFE), help doctors identify the IgD subtype and measure how much abnormal protein is present
- Knowing the subtype helps doctors understand how active the cancer is and choose the most appropriate treatment plan Because IgD myeloma is rare, it's especially important to work closely with a specialist who has experience with this subtype. They can help tailor a treatment plan that fits the specific behavior of IgD myeloma. Don't hesitate to ask your care team questions — no question is too small when it comes to understanding your diagnosis.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

IgG and IgA Antibodies in Myeloma: Which Is More Aggressive?